Norris Medicines Limited (BOM:524414)

Norris Medicines Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	130	168	136	105	350	65
Market Cap Growth	-39.25%	23.38%	30.14%	-70.10%	437.69%	131.32%
Enterprise Value	344	383	351	319	550	241
Last Close Price	13.00	16.78	13.60	10.45	34.95	6.50
PS Ratio	1.38	2.88	2.41	1.25	3.70	0.53
PB Ratio	-0.82	-1.13	-1.00	-0.84	-3.27	-0.87
P/FCF Ratio	-	34.17	80.65	8.94	-	6.34
P/OCF Ratio	-	32.90	80.11	8.71	-	5.84
EV/Sales Ratio	3.64	6.59	6.23	3.82	5.83	1.96
EV/EBITDA Ratio	72.64	-	-	34.52	-	-
EV/EBIT Ratio	-	-	-	108.08	-	-
EV/FCF Ratio	-	78.09	208.24	27.30	-	23.46
Debt / Equity Ratio	-1.35	-1.45	-1.58	-1.72	-1.97	-2.47
Debt / EBITDA Ratio	45.33	-	-	23.13	-	-
Debt / FCF Ratio	-	43.95	127.63	18.30	-	17.93
Net Debt / Equity Ratio	-1.35	-1.45	-1.58	-1.72	-1.97	-2.47
Net Debt / EBITDA Ratio	45.19	-97.40	-120.43	23.11	-334.03	-10.54
Net Debt / FCF Ratio	-	43.87	127.41	18.28	-19.78	17.91
Asset Turnover	-	0.42	0.40	0.60	0.56	0.61
Inventory Turnover	-	0.83	0.72	1.25	1.48	1.91
Quick Ratio	-	0.14	0.12	0.14	0.16	0.16
Current Ratio	-	0.63	0.67	0.64	0.63	0.70
Return on Assets (ROA)	-	-3.38%	-3.36%	1.32%	-2.65%	-7.46%
Return on Invested Capital (ROIC)	-0.68%	-10.44%	-8.93%	3.06%	-6.76%	-18.30%
Return on Capital Employed (ROCE)	-	-20.70%	-15.10%	4.90%	-9.70%	-29.80%
Earnings Yield	-4.31%	-7.37%	-8.72%	-16.74%	-9.34%	-76.33%
FCF Yield	-	2.93%	1.24%	11.19%	-3.05%	15.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.